chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a nurse refers to an unknown number of patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unknown dates, reported as since December 2013, the patient were possibly administered doses of VARIVAX (Merck) injection (dose, route and lot number were not reported) which were not stored properly. No adverse effects were noted. Concomitant medications were not specified. This is one of several reports received from the same reproter. Additional information has been requested.
Information has been received from a company representative from a physician concerning a female patient who on an unspecified date was re vaccinated (after 5 years) with pneumococcal 23v polysaccharide vaccine (Lot# not provided).  The patient recovered subsequently developed an unspecified injection site reaction.  The patient recovered from the injection site reaction with out any intervention.  Additional information has been requested.
Pt arm started to swell right away popping bandaids  off. She took Benadryl and put ice pack on and waited for a bit. I checked no trouble breathing or hives or any other reactions. Pt had to leave so I called her later that night to check but not home so I left message. Pt called next day and said still swollen even more and bruised possible slight fever that night but she wasn?t positive.
For the first day or two after the 2nd Moderna shot, I had some achy and fever symptoms. Then nothing until 6/10/2021 when I developed symptoms of Bells Palsy. Not sure if related to the vaccine but wanted to submit VAERS report just in case it's related.
herpes zoster; Information has been received regarding a case in litigation from a lawyer concerning a currently 65 year old female patient. Her medical history, concurrent conditions and concomitant medications were not reported.     On an unspecified date in 2017, the pt was vaccinated with a dose of zoster vaccine live(ZOSTAVAX) for the long term prevention of shingles and zoster-related conditions (Strength, dose, route of administration, lot # and expiration date were not reported).        On an unknown date, Plaintiff was treated by a healthcare provider for the following injuries resulting from Plaintiff's zoster vaccine live(ZOSTAVAX) use: herpes zoster. Plaintiff bring this action on behalf of herself, claiming damages as a result of injury to herself, loss of consortium, loss of services and economic losses.  The outcome of herpes zoster was unknown.    The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
10 Min after vaccine pt had throat tighten flushed, dizziness, palpitations. Pt did not tell staff @ site about her symptom. She waited 45 min and went home. She has had continued throat tightness FoR 5 days.
BODY ACHES; FELT HOT; BAD HEADACHE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 10:30 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced felt hot. On 08-APR-2021, the subject experienced bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, felt hot, and bad headache on 10-APR-2021. This report was non-serious.
This case was reported by a consumer and described the occurrence of injection site discomfort in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site discomfort and muscle discomfort. On an unknown date, the outcome of the injection site discomfort and muscle discomfort were unknown. It was unknown if the reporter considered the injection site discomfort and muscle discomfort to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient had the 1st dose of SHINGRIX vaccine 2 days ago from the date of reporting. Almost 48 hrs the patient have not had any side effects, other than mild discomfort of muscle at injection site. The patient was asking that did this mean the vaccine was not effective.
kidney pain, painful numbness in hands, severe sensitivity to touch, hair tingling, muscle pain, testicles feel swollen (they are not) and painful,
Onset of cold and flu symptoms within 3 hours of receiving the COVID vaccine shot. Mild fever initially (later resolved), runny nose (constantly)  deep chunky cough, flushed skin, feels tired.
It was reported that a female pt received a Fluzone SV '99-'00 vaccination on 10/28/99. Reportedly, within 5 hours, post vax. the pt developed urticaria.
Case number PHEH2015US024709, is an initial spontaneous report from a consumer (patient's mother) received on 23 Nov 2015. This report refers to a 7 years old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: unknown) intramuscularly on an unknown date. On 20 Nov 2015 the patient felt itchy and experienced hives. The patient was treated with BENADRYL and within an hour the hives went down. On 21 Nov 2015 (almost 24 hours later) the hives came back but not bad as the first day. The patient was treated with ALLEGRA. Further it was reported that the hives came back again on 22 Nov 2015 and the pediatrician was aware of the same. Final outcome of the events was condition unchanged. The seriousness and causality of the events was not reported.
Developed severe hives all over patients back.  Itching.  Rash started to develop on chest.  Took Benadryl and by morning the rash was subsiding.  No other allergic symptoms.
Information has been received from a Nurse Practitioner concerning a 24 year old female patient with no known drug allergies or reactions who in April 2010, was intramuscularly vaccinated with the first dose of GARDASIL (Lot # and expiration not reported) and in April 2011 was intramuscularly vaccinated with the second dose of GARDASIL (lot # and expiration not reported). The nurse reported that the patient received the first dose of GARDASIL with no complications and 3 days after the second dose of GARDASIL (in April 2011) developed a fever and rash around the injection site which lasted a week. The patient sought unspecified medical attention (called clinic). Unspecified medication was given for the adverse events. At the time of reporting the patient had recovered. Additional information has been requested.
p/vax pt c/o achiness & fatigue;next AM had n/v & h/a;approx 30hr p/vax had gen sz x <2min;gen sz x 1min by 72 p/vax back to baseline;
Information has been received from a health professional concerning a 21 year old female who on 27-DEC-2007 was IM vaccinated with her first dose of Gardasil (lot number unspecified).  On 17-Mar-2008 the patient was IM vaccinated with her second dose of Gardasil (lot number unspecified) at another physician's office.  On 20-Mar-2008 the patient was due for her DEPO-PROVERA shot but was given Gardasil (lot number unspecified) by mistake.  The office manager reports this was a communication error not a product confusion.  The patient did not inform the office that a second dose was given on 17-Mar-2008.  The patient sought unspecified medical treatment by calling the nurse.  No adverse reactions were reported and no other information was available to the office manager.  Additional information has been requested.
Severe Pain in left neck and left arm; Severe Pain in left neck and left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), on 07Jan2022 at 16:00 as dose 3 (booster), single (Lot number: Fl3209), in left arm for covid-19 immunisation. The patient's relevant medical history included: "neck diagnosis issue", notes: from over 10 years ago. Concomitant medication(s) included: NASONEX; SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]. Vaccination history included: BNT162b2 (DOSE 1, LOT NO: En6199, LOCATION: Left arm), administration date: 13Mar2021, for COVID-19 immunization; BNT162b2 (DOSE 2, LOT NO: Er8734, LOCATION: Left arm), administration date: 03Apr2021, for COVID-19 immunization. The following information was reported: NECK PAIN (non-serious), VACCINATION SITE PAIN (non-serious), outcome "unknown" and all described as "Severe Pain in left neck and left arm". Therapeutic measures were taken as a result of neck pain, vaccination site pain. Additional information: The patient have no known allergies. Patient have no other vaccine in four weeks. Patient have no COVID prior to vaccination. None of us have had any issues with our necks or arms up to this year from previous issue. Seems like to much of a coincidence that it's not either a side effect of the vaccine or a side effect of COVID. Sender's Comments: Linked Report(s) : US-PFIZER INC-202200828045 same reporter/product/event, different patient; US-PFIZER INC-202200828043 same reporter/product/event, different patient; US-PFIZER INC-202200828046 same reporter/patient, different dose/event;
was sicker than had been in a while; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 03-Dec-2020.  This case involves unidentifiable patient who was sicker than had been in a while (illness) while the patient received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown.  On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, the patient was sicker than had been in a while (illness) following the administration of INFLUENZA VACCINE.  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
EMS dispactched to scene of home with CPR in progress. Pt. was in VTACH and shocked X1, Epinephine X 2, Bicarb X 1. Return of circulation which was lost enroute to ED. CPR started again.  Blood/Frothy sputum noted from tube and mouth. pupils 3 mm, sluggish. mottled skin in exremities. Glasgow coma score of 3.  In the ED Epi, bicarb, Ketalar, Lasix, CaCL, norepi Pt. transfered by helicopter to  higher level of care,
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 23-AUG-2016, the patient was vaccinated with incorrectly stored dose of M-M-R II lot # L026553, therapy type was not specified (dose and route of administration were not reported). This is one of several reports received from the same source. Additional information has been requested.
Patient presented to  pharmacy alone requesting a COVID vaccine.  Unknown to us patient had a hx of dementia.  J&J vaccine was administered.  Shortly after vaccine administration we received a call from the patient's son stating he had already completed a Pfizer COVID vaccine series in January through the VA.  We advised the son to watch for any unusual signs or symptoms and f/u with the patients care provider if anything unusual occurs.
This spontaneous report was received from a healthcare worker refers to a patient of unknown demographics. On 10-MAR-2014 the patient was vaccinated with RECOMBIVAX HB (dosing regimen unspecified). No concomitant medications were reported. On an unknown date medication error was reported as the patient received doses on 10-MAR-2014 that were exposed to temperatures outside of the recommended storage range noted in the prescribing information. No adverse effect reported. No product quality complaint involved. The outcome of medication error was unknown. This case is linked to: 1403USA005417, 1403USA011256, 1403USA011268, 1403USA011301, 1403USA011335, 1403USA011343, 1403USA011350, 1403USA011353, 1403USA011356, 1403USA011363, 1403USA011380, 1403USA011414, 1403USA011416, 1403USA011418, 1403USA011420, 1403USA011422, 1403USA011424, 1403USA011425, 1403USA011427. (same reporter link) Additional information has been requested.
Incredible fatigue, cough, cold symptoms, runny nose, itchy eyes. The fatigue lasted about 3.5 weeks. I still have a tickle in my throat. I was given Paxlovid.
Dizziness; Cough; Hives on the face/ hives on her chest,neck and back; Expired vaccine used; This is a spontaneous case initially received from a pharmacist on 03-Dec-2018, concerning a 34-year-old, adult female patient.  On an unspecified date in the past, the patient had received an unspecified vaccine as immunization for an unknown indication and had got queasy and blackout. It was reported that the patient was fine after some time of receiving vaccine. The patient's current condition included allergic rhinitis due to pollen (reported as medical history). The patient did not receive any concomitant medications.  On 11-Oct-2018, the patient was administered Afluria Quadrivalent (influenza vaccine, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: YF38807 and expiry date: 30-Jun-2018) (explicitly coded as expired vaccine used) for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. On the same day, the patient was administered a non-company suspect vaccine pneumococcal vaccine (reported as pneumonia vaccine) (pneumococcal vaccine, dose, route of administration, anatomical location, batch number and expiry date: not reported) for an unknown indication.  On the same day, 2 hours after vaccination, the patient experienced dizziness and cough. The patient also experienced hives on the face 8 hours after vaccination. Between 10 and 11 hours after vaccination, the patient experienced hives on her face, chest, neck and back. The patient was treated with Benadryl by doctor's indication. The next day, she was feeling better.  The outcome of the events was recovered on 12-Oct-2018.  The reporter assessed the case as non-serious and the events as related to the suspect vaccine.  Non-significant follow up received from the reporter on 04-Feb-2019: The Info reference number (SEQ19-00079) was added in the additional information tab. no changes were made in the narrative.; Reporter's Comments: A 34-year-old, female patient experienced dizziness, cough, and hives on the same day after vaccination with the expired suspect vaccine Afluria Quadrivalent (coded as expired vaccine used) and non-company suspect vaccine pneumococcal vaccine. The company assessed the causality of the events as related to the suspect vaccine due to plausible temporal relationship between events and suspect vaccine. The company assessed the causality of the event expired vaccine used as not related to the suspect vaccine due to accidental nature of the event.
bruising; headache; Arm pain; pain throughout the body especially legs and lower back; pain throughout the body especially legs and lower back; tiredness; nausea; fever; blurred vision; This is a spontaneous report from a Contactable consumer. This 48-year-old Female consumer reported for herself. A 48-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EW0196), dose 2 via an un-specified route of administration, administered in Arm Left in Arm Left on 14Jul2021 10:00 as dose 2, single (age at vaccination 48-years-old) for covid-19 immunization. Medical history and concomitant medications were not reported. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EW0196), via an unspecified route of administration, administered in Arm Left on 23Jun2021 at 10:00 as dose 1, single for COVID-19 Immunization. On15Jul2021 01:00 Am, the patient experienced bruising, headache, arm pain, pain throughout the body especially legs and lower back, pain throughout the body especially legs and lower back, tiredness, nausea, fever, blurred vision. Patient received Tylenol as treatment for events. The outcome of events were recovered in 2021.  Follow-up attempts are completed. No further information is expected.
Achy; warm; tired; This is a spontaneous report from a contactable consumer, the patient. A 61-years-old non-pregnant female patient received first single dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534), via an unspecified route of administration on left arm on 16March2021 at 16:30 for COVID-19 vaccination. Medical history included familial medullary thyroid carcinoma for past 30 years. It is unknown whether the patient was having any known allergies. The concomitant medications included SYNTHROID 200mg, DIEHTYLPROPIONER 75 mg. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient not had any symptoms associated with COVID-19. The patient did not receive any other vaccine within four weeks prior to vaccine. On 18Mar2021 at 12:00 (started two days after the first dose), the patient feels achy, warm and tired starting around noon each day. The patient had not running a temperature. It was reported that, the patient working from home, so had not been anywhere when it started, other than getting the Patients first vaccination. It's a daily recurrence. The patient did not receive any other treatment for the adverse event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events ache, warm and tired was not resolved at the time of this report.   No follow up attempts are needed. No further information is expected.
Within ten (10) minutes of receiving second Covid-19 Pfizer vaccine, my left arm and hand went numb and tingly.  An attending nurse completed various tests ruling out emergency treatment at that time, indicating I should see advice from my Primary Care Physician if side affects persisted the next day.  The following day, the numbing/tingling expanded from the top of my head, all the way down the left side of my face, neck, arm, hand, lower leg and foot.  I was seen by my Primary Care Physician who directed me  immediately to the Emergency Room of Medical Center, as he thought I could be having a stroke or have a blood clot due to the affects of the Covid-19 Pfizer vaccine. With my symptoms continuing and worsening and blood pressure extremely high, I had blood drawn, was given an EKG and a CT Scan in the ER.  A neurologist was also consulted who indicated my symptoms heard of after the vaccine but never seen in person.  I was referred by the attending ER Physician, Dr., to follow up with the neurologist, Dr., and was given an appointment for Friday, April 23. 2021.  I was evaluated, then scheduled and received a brain MRI with and without contrast on Wednesday, April 28, 2021.  Tests given at the time in the ER and with the neurologist appeared to show no signs of a stroke, lesions, masses or a heart attack.  The numbing/tingling continued with my left arm, leg and foot continuously for two weeks and moved around to other parts of my body for shorter periods of time during the duration.  After the two weeks, the numbing/tingling sensation appears and disappears quickly (within 30 seconds) in my left arm/hand and left foot.  This does not occur every day but still happens very sporadically.  Note:  The numbing/tingling sensation I felt within my head/face/neck area was consistent with the feeling of receiving novocaine. Please Note:  Approximately 30 minutes after my first Covid-19 Pfizer vaccine, I experienced a numb/tingling in my tongue with slight discomfort and the sensation I had eaten something very acidic.   I experience the same sensation at times after eating tomatoes or oranges.   I could feel my uvula when swallowing and drank a tremendous amount of water.  My throat did not close, nor did I have difficulty breathing.  I took a Benadryl tablet before bedtime, and the sensation was gone the next morning.  I mentioned this affect before receiving my second dose of the Covid-19 Pfizer vaccine.  The nurse checked with others, and it was decided I would be kept for 30 minutes for observation instead of the usual 15 minutes following the vaccine.
PENTACEL given on right thigh 8/8/17. Redness developed shortly after. Next morning mother noted increased redness, warmth, and induration. On PE: 3-4cm round, indurated, slightly warm lesion on right upper thigh.
03/10/2021, As soon as the injection went into my left arm, my tongue went numb and also part of my right side of my face went numb,  I had burning sensation on my left arm and through my chest. The next 2 weeks I took Benadryl because my tongue was still numb. I also had brain fog and felt lethargic, I felt tired and the muscles in my legs feel tired and heavy. I called my NP right away and they just suggested not to get my 2nd Dose and continue taking Benadryl. As of today, my tongue is still numb, I still have brain fog, and I still feel lethargic.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Mar2022 at 10:00 as dose 4 (booster), single (Lot number: fk7894) at the age of 72 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for 1 day, as dose 2, single (Batch/Lot number: unknown) for 1 day and as dose 3 (booster), single (Batch/Lot number: unknown) for 1 day for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications/Other medication in 2weeks.No known allergies The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: still present on day 15 with positive covid antigen test; Negative, notes: testing negative on days 6,7,8,9 and 10. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: COVID 19 Treatment with pfizer product Paxlovid started on 21Jul2022 and stop on 26Jul2022. Paxlovid rebound on day 11 - new sore throat, cold symptoms still present on day 15 with positive covid antigen test after being asymptomatic and testing negative on days 6,7,8,9 and 10.; Sender's Comments: Based on the available reported information, the causal association between the events and the suspect drug BNT162B2 cannot be excluded.
<10minutes s/p vaccine administration of Janssen COVID19, patient stated he was feeling faint. He was visually pale in the face, slightly slumped. No reports of trouble breathing/swelling/rash/hives. instructed patient to lay down if needed. Drank water. He started to feel better after 15 minutes; however,  patient stayed 30 minutes till leaving pharmacy.
pt recv vax;exp severe abd pain,cramping,v & d;exp delayed menses w/ both doses of vax;MD reported that pt had a hx of very regular menses & was never late;
pt recvd vax & w/in 24hrs post vax pt exp nausea which lasted about 1month;sx subsided;